Company Monitoring Page for Eisai

latest headlines for company on cafepharma

Arena Pharmaceuticals receives $500K milestone payment from Eisai
Yahoo/Fly on the Wall
Wed, 06/26/13 - 10:39 am
Tags:
Arena Pharmaceuticals, Eisai, milestone payments, Belviq
Arena's Belviq Discounts And Impacts On Revenue
Seeking Alpha
Mon, 06/10/13 - 05:06 am
Tags:
Belviq, Arena Pharmaceuticals, Eisai, drug discounts
2 Under-Covered Pharma Stocks With Yields Above 3%
Seeking Alpha
Wed, 06/5/13 - 11:34 am
Tags:
Eisai, Bristol-Myers Squibb, Eli Lilly, AstraZeneca, Lonza
Arena: Marketing An Anti-Obesity Drug
Seeking Alpha
Thu, 05/30/13 - 09:03 am
Tags:
Arena Pharmaceuticals, obesity, Vivus, Orexigen, Belviq, Qsymia, Eisai
The Facebook Effect On Arena's Belviq Sales And Why It Will Ultimately Dwarf Anything Eisai Does
Seeking Alpha
Tue, 05/21/13 - 11:00 am
Tags:
Arena Pharmaceuticals, obesity, Belviq, Vivus, Qsymia, Eisai, social media, Facebook
Arena Outlines Belviq Launch And Goals
Seeking Alpha
Fri, 05/17/13 - 11:27 am
Tags:
Belviq, Arena Pharmaceuticals, drug launches, Eisai
Obesity Drug Demand Still Low
Motley Fool
Thu, 05/9/13 - 09:32 am
Tags:
obesity, Vivus, Arena Pharmaceuticals, Qsymia, Belviq, Eisai
Eisai/Arena obesity drug gets all-clear for June launch
Pharma Times, UK
Wed, 05/8/13 - 10:49 am
Tags:
drug launches, Eisai, Arena Pharmaceuticals, Belviq, obesity
3 Bio Companies Facing The Patent Cliff
Seeking Alpha
Tue, 05/7/13 - 05:31 pm
Tags:
patents, patent cliff, AbbVie, BiogenIdec, Eisai, JNJ, Eli Lilly, Novartis, Sanofi, Roche
Netupitant Results Could Roil Tesaro In May
Seeking Alpha
Mon, 05/6/13 - 10:48 am
Tags:
Tesaro, Netupitant, breast cancer, ovarian cancer, niraparib, Sanofi, Roche, OPKO Health, Merck, GSK, Eisai
Biotech startup hustles new Alzheimer's program to the clinic
Fierce Biotech
Fri, 04/26/13 - 11:53 am
Tags:
Alzheimer's disease, Targretin, Eisai, ReXceptor
Arena Faces A Convergence Of DEA And European Decisions
Seeking Alpha
Wed, 04/24/13 - 10:25 am
Tags:
Arena Pharmaceuticals, Europe, DEA, Eisai, Vivus, Orexigen
As Arena Pharma Begins To Address Mexican Obesity, All Eyes Are Now On The DEA
Seeking Alpha
Mon, 04/8/13 - 11:39 am
Tags:
Arena Pharmaceuticals, Mexico, obesity, Vivus, APD811, Belviq, Eisai
Eisai fires back at G-BA rebuff of Fycompa
Fierce Pharma
Fri, 03/8/13 - 11:18 am
Tags:
Eisai, Fycompa, epilepsy
When Will This Obesity Drug Launch?
Motley Fool
Tue, 03/5/13 - 10:43 am
Tags:
obesity, Arena Pharmaceuticals, drug launches, Belviq, Eisai
A Drug That's Ready to Lose
Motley Fool
Thu, 02/28/13 - 11:30 am
Tags:
Belviq, Arena Pharmaceuticals, Vivus, Eisai
Will There Ever Be an Obesity Drug Blockbuster?
Motley Fool
Sun, 02/17/13 - 12:02 pm
Tags:
obesity, weight loss, Arena Pharmaceuticals, Eisai, Belviq, Qsymia, Orexigen
Eisai gets orphan drug status for Lenvatinib
Marketwatch
Fri, 02/15/13 - 11:09 am
Tags:
Eisai, orphan drugs, Lenvatinib, thyroid cancer
13 Biotech Stock Predictions for 2013
TheStreet.com
Wed, 01/2/13 - 12:18 pm
Tags:
Eisai, Sarepta, Arena Pharmaceuticals, Amarin, Gilead, Biomarin, Onyx, Medivation, Achillion, Incyte, Cell Therapeutics, Celgene, NPS Pharmaceuticals, Aegerion, Roche, Biogen Idec, Ariad Pharmaceuticals, Alexza, Navidea, Aveo
Arena's Marketing Partner Eisai Pharma Seeks Expedited Final Ruling From DEA To Begin Belviq Sales
Seeking Alpha
Mon, 12/24/12 - 10:37 am
Tags:
Arena, Eisai, Belviq

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.